Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -114.65% is 312% below its 5-year average of -27.81%, near the low end of its 5-year range (-114.65%–-0.91%).
As of the fiscal period ended Tuesday, June 30, 2026. 83.61% below its 12-month average of -62.44%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -114.65%.
RETURN ON INVESTED CAPITAL (ROIC)
-114.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-62.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-27.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-83.61%
CURRENT VS 3Y AVG
-318.85%
CURRENT VS 5Y AVG
-312.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-221.64%
vs the sector median at left
ARS Pharmaceuticals, Inc.
Market Cap
$427.00M
Return on Invested Capital (ROIC)
-114.65%
TTM Avg
-62.44%
3Y Avg
-27.37%
5Y Avg
-27.81%
Market Cap
$427.33M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
Market Cap
$425.79M
Return on Invested Capital (ROIC)
-2.98%
TTM Avg
-62.76%
3Y Avg
-40.63%
5Y Avg
-28.06%
Market Cap
$425.09M
Return on Invested Capital (ROIC)
-48.61%
TTM Avg
-80.33%
3Y Avg
-62.04%
5Y Avg
-50.84%
Market Cap
$420.92M
Return on Invested Capital (ROIC)
-21.36%
TTM Avg
-47.45%
3Y Avg
-35.84%
5Y Avg
-28.07%
Market Cap
$418.15M
Return on Invested Capital (ROIC)
-71.22%
TTM Avg
-79.15%
3Y Avg
-65.81%
5Y Avg
-107.73%
Market Cap
$436.95M
Return on Invested Capital (ROIC)
-41.88%
TTM Avg
-37.25%
3Y Avg
-52.62%
5Y Avg
-51.87%
Market Cap
$438.67M
Return on Invested Capital (ROIC)
-2.86%
TTM Avg
-34.72%
3Y Avg
-61.44%
5Y Avg
-57.77%
Market Cap
$411.21M
Return on Invested Capital (ROIC)
-69.35%
TTM Avg
-52.27%
3Y Avg
-73.46%
5Y Avg
-73.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | $427.00M | -114.65% | -62.44% | -27.37% | -27.81% |
| NeoGenomics, Inc. (NEO)vs › | $427.33M | -5.29% | -5.58% | -6.88% | -5.95% |
| Tilray Brands, Inc. (TLRY)vs › | $425.79M | -2.98% | -62.76% | -40.63% | -28.06% |
| Editas Medicine, Inc. (EDIT)vs › | $425.09M | -48.61% | -80.33% | -62.04% | -50.84% |
| Prothena Corporation plc (PRTA)vs › | $420.92M | -21.36% | -47.45% | -35.84% | -28.07% |
| Senseonics Holdings, Inc. (SENS)vs › | $418.15M | -71.22% | -79.15% | -65.81% | -107.73% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $436.95M | -41.88% | -37.25% | -52.62% | -51.87% |
| Assembly Biosciences, Inc. (ASMB)vs › | $438.67M | -2.86% | -34.72% | -61.44% | -57.77% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | -69.35% | -52.27% | -73.46% | -73.46% |
| NeuroPace, Inc. (NPCE)vs › | $438.45M | -18.95% | -22.72% | -28.68% | -26.80% |
ROIC
-114.7%
ROE
-1721.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -114.65% |
| 2026-03-31 | -85.06% |
| 2025-12-31 | -62.20% |
| 2025-09-30 | -28.15% |
| 2025-06-30 | -22.15% |
| 2025-03-31 | -9.03% |
| 2024-12-31 | -0.91% |
| 2024-09-30 | -30.11% |
| 2024-06-30 | -26.36% |
| 2024-03-31 | -27.69% |
| 2023-12-31 | -29.23% |
| 2023-09-30 | -30.61% |
| 2023-06-30 | -24.68% |
| 2023-03-31 | -18.02% |
| 2022-12-31 | -12.87% |
| 2022-09-30 | -71.68% |
| 2022-06-30 | -57.06% |
| 2022-03-31 | -7.40% |
| 2021-12-31 | -34.29% |
| 2021-09-30 | -8.16% |
